These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10734227)

  • 1. Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M; Bartkova J; Khan S; Hansen K; Rönnstrand L; Lukas J; Strauss M; Bartek J
    FEBS Lett; 2000 Mar; 470(2):161-6. PubMed ID: 10734227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
    Parry D; Mahony D; Wills K; Lees E
    Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
    Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ
    Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
    Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
    Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
    Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
    J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors.
    Jeffrey PD; Tong L; Pavletich NP
    Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Pinto A; Demetrick DJ; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2000 Sep; 29(1):63-9. PubMed ID: 10918395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines.
    Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V
    J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor INK4: quantitative structure-function analyses of p18INK4C as an inhibitor of cyclin-dependent kinase 4.
    Li J; Poi MJ; Qin D; Selby TL; Byeon IJ; Tsai MD
    Biochemistry; 2000 Feb; 39(4):649-57. PubMed ID: 10651629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
    Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
    Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
    Fink JR; LeBien TW
    Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The INK4 family of CDK inhibitors.
    Carnero A; Hannon GJ
    Curr Top Microbiol Immunol; 1998; 227():43-55. PubMed ID: 9479825
    [No Abstract]   [Full Text] [Related]  

  • 15. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
    Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
    Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
    Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
    Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
    Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
    Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.